Medtech Archives - Boston Life Sciences Times

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

THIS WEEK'S STORIES

Thermo Fisher Scientific Launches CorEvitas Clinical Registry for Myasthenia Gravis to Advance Real-World Research in Rare Autoimmune Disease

November 17, 2025

RapidAI Earns FDA Clearance for Rapid Aortic, Bringing AI-Driven Aortic Measurements and Surveillance to Care Teams

November 18, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

CurvaFix Expands National Market Access with Premier Inc. Breakthrough Designation for Orthopedic Trauma Products

VahatiCor Closes Oversubscribed Series B to Accelerate A-FLUX Development for Coronary Microvascular Dysfunction

Cognision Partners with Kynexis to Use COGNISION System in Phase 2 Trial of KYN-5356 for Schizophrenia

Carilion Clinic and Mevion Medical Systems Partner to Bring Proton Therapy to Southwest Virginia

Hologic Expands Genius Digital Diagnostics System With CE Marking for Digital Pathology

Most Read

RapidAI Earns FDA Clearance for Rapid Aortic, Bringing AI-Driven Aortic Measurements and Surveillance to Care Teams

Valent BioSciences and Seipasa Form Strategic Partnership to Bring Novel Biostimulant Products to U.S. Agriculture

CoapTech Announces Leadership Transition; Board Appoints Brad Kreger as Chief Executive Officer

CurvaFix Expands National Market Access with Premier Inc. Breakthrough Designation for Orthopedic Trauma Products

EDITOR PICKS

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

THIS WEEK'S STORIES

Thermo Fisher Scientific Launches CorEvitas Clinical Registry for Myasthenia Gravis to Advance Real-World Research in Rare Autoimmune Disease

RapidAI Earns FDA Clearance for Rapid Aortic, Bringing AI-Driven Aortic Measurements and Surveillance to Care Teams

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

POPULAR CATEGORY

ABOUT US

FOLLOW US